Skip to content

Howard Hughes Medical Institute: KLAC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Howard Hughes Medical Institute on KLAC, newest first. How the timeline and the estimate are built.

Howard Hughes Medical Institute held 18,250 KLAC shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 18,250 shares
    Change vs previous 13F +16,425 shares

    1.24% of the 13F portfolio, value $5,506,208.

    13F-HR 0001193125-26-350254 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,825 shares
    Change vs previous 13F +1,797 shares

    0.65% of the 13F portfolio, value $2,687,148.

    13F-HR 0001193125-26-225362 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 28 shares
    Change vs previous 13F 0 shares

    0.02% of the 13F portfolio, value $34,022.

    13F-HR 0001193125-26-052983 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 28 shares
    Change vs previous 13F 0 shares

    0.02% of the 13F portfolio, value $30,201.

    13F-HR 0001193125-25-281376 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 28 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $25,081.

    13F-HR 0000950123-25-007937 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).